Screening of potential donors for immunoglobulins M and G to new coronavirus infection

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

This study presents the results of the examination of potential donors of blood and its components for immunoglobulins M and G to patients with coronavirus disease 2019 (COVID-19) living in St. Petersburg. A total of 6782 people aged 18−24 years were evaluated, which accounted for 2.07% of the region’s population (326 760 people) of this age group. The study was carried out in the spring and autumn of 2020. A negative result (absence of antibodies) was obtained in 93.5% of the participants. The rates of immunoglobulins M and M + G were 0.58% and 4.18%, respectively, in the spring and autumn. Moreover, the number of participants who had immunoglobulins M and G + M in the autumn period was four times higher than the indicators of the spring period, which indicated greater infection activities in the population during this period. This is most likely due to the active movement of the population in the summer. When comparing the rates of COVID-19 infection and the frequency of occurrence in donors of the same age, markers of human immunodeficiency virus 1 and 2 and hepatitis B and C in 2020 (0.024, 0.012 and 0.13%, respectively) indicate the urgency of the problem of donor selection during blood services, especially during a difficult epidemiological situation because of COVID-19. Along with organizational measures for the selection of donors (e.g., attracting individuals from organized groups in which there are no signs of an unfavorable epidemiological situation to donation), mandatory testing of potential donors for immunoglobulins M and G should be considered.

作者简介

Yuliia Romashova

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

编辑信件的主要联系方式.
Email: juliamirkina@gmail.com

manager

俄罗斯联邦, Saint Petersburg

Vladimir Vilyaninov

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: vilyaninov@mail.ru

candidate of medical sciences, associate professor

俄罗斯联邦, Saint Petersburg

Nikolay Belgesov

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: bnv538@mail.ru

candidate of medical sciences

俄罗斯联邦, Saint Petersburg

Sergey Kaleko

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: i.beger2014@yandex.ru

candidate of medical sciences

俄罗斯联邦, Saint Petersburg

参考

  1. Supotnickij MV. Novyj koronavirus SARS-CoV-2 v aspekte global’noj jepidemiologii koronavirusnyh infekcij. Vestnik vojsk RHB zashhity. 2020;1(4):32−65. (In Russ.). doi: 10.35825/2587-5728-2020-4-1-32-65
  2. Tolstykh VV, Yampol’skii SM. Vliyanie pandemii koronavirusa COVID-19 na deyatel’nost’ vooruzhennykh sil Rossiiskoi Federatsii i inostrannykh armii po obespecheniyu oboronosposobnosti gosudarstva. Natsional’naya bezopasnost i strategicheskoe planirovanie. 2020;3(31):30−36. (In Russ.).
  3. Upravlenie Federal`noj sluzhby gosudarstvennoj statistiki po g. Sankt-Peterburgu i Leningradskoj oblasti (Petrostat). Vozrastno-polovoj sostav naseleniya Sankt-Peterburga na 1 yanvarya 2020 goda. Statisticheskiy byulleten. 2020;(VS-140/1245):5–10. (In Russ.).
  4. Bloch E, Shoham S, Casadevall A. Deployment of convalescent plasma for the prevention and treatment of COVID-19. Journal of Clinical Investigation. 2020;6(103):2757−2765. doi: 10.1172/JCI138745
  5. Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 2020;20(4):398−400. doi: 10.1016/S1473-3099(20)30141-9

补充文件

附件文件
动作
1. JATS XML

版权所有 © Romashova Y.E., Vilyaninov V.N., Belgesov N.V., Kaleko S.P., 2021

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

##common.cookie##